- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies
U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies
UPDATED May 20, 2022
Companies with a Value score of at least 3, ordered by Value score
209 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CPHR.FCipher Pharmaceuticals | US$1.82 | -3.3% | 51.5% | US$60.8m | US$2.66 | PS5.5x | E7.9% | n/a | ||
| APNH.FAspen Pharmacare Holdings | US$10.75 | 0% | n/a | US$71.4b | US$16.82 | PS12.1x | E20.4% | 1.7% | ||
| QUREuniQure | US$13.72 | -4.1% | -59.6% | US$625.5m | US$53.71 | PS2x | E22.5% | n/a | ||
| APNH.YAspen Pharmacare Holdings | US$9.61 | 0.1% | -19.0% | US$71.4b | US$15.04 | PS12.1x | E20.4% | 1.7% | ||
| GEDS.FRichter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt | US$20.90 | 6.1% | n/a | US$1.4t | US$24.33 | PS10x | E16.4% | 3.0% | ||
| RGED.FRichter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt | US$24.63 | 25.0% | -15.1% | US$1.4t | US$28.67 | PS10x | E16.4% | 3.0% | ||
| EBSEmergent BioSolutions | US$35.33 | 22.9% | -39.6% | US$1.6b | US$44.50 | PS11.3x | E21.2% | n/a | ||
| CHIZ.FChina Traditional Chinese Medicine Holdings | US$0.46 | 0% | n/a | US$19.7b | n/a | PS8.7x | E13.6% | 3.6% | ||
| AVIRAtea Pharmaceuticals | US$7.49 | 2.7% | -66.6% | US$603.6m | US$10.25 | PS12.9x | E45.3% | n/a | ||
| CSWY.FChina Shineway Pharmaceutical Group | US$0.73 | 0% | n/a | US$4.5b | n/a | PS7x | E10.3% | 7.6% | ||
| ULIH.FUnited Laboratories International Holdings | US$0.50 | 0% | n/a | US$6.8b | n/a | PS5.8x | E9.0% | 5.0% | ||
| KDCEKid Castle Educational | US$0.05 | 0% | n/a | US$1.1m | n/a | n/a | n/a | n/a | ||
| PHMM.FPharma Mar | US$77.00 | 0% | -21.2% | US$1.3b | US$87.24 | PS13.9x | E23.3% | 0.9% | ||
| SNPH.YSanten Pharmaceutical | US$7.88 | -1.1% | -40.3% | US$403.1b | US$11.55 | PS14.8x | E2.5% | 3.2% | ||
| SNPH.FSanten Pharmaceutical | US$7.80 | -3.4% | -40.9% | US$403.1b | US$11.44 | PS14.8x | E2.5% | 3.2% | ||
| HALOHalozyme Therapeutics | US$44.32 | 9.6% | 5.0% | US$6.0b | US$49.13 | PS14x | E15.9% | n/a | ||
| COLLCollegium Pharmaceutical | US$16.36 | 4.6% | -34.6% | US$542.9m | US$28.86 | PS13x | E33.1% | n/a | ||
| YOUR.FYourWay Cannabis Brands | US$0.08 | 29.0% | -58.5% | US$23.2m | n/a | PS6.1x | n/a | n/a | ||
| GNML.FGenomma Lab Internacional. de | US$1.03 | -8.0% | 0% | US$20.9b | US$1.29 | PS14.2x | E16.1% | 1.8% | ||
| HYPM.YHypera | US$8.30 | 12.6% | 24.8% | US$23.3b | US$9.81 | PS14x | E18.3% | 3.3% | ||
| SOLC.FSOL Global Investments | US$0.55 | -15.6% | -81.0% | US$33.5m | n/a | n/a | n/a | n/a | ||
| RGNXREGENXBIO | US$20.08 | -3.6% | -42.8% | US$847.6m | US$51.33 | PS8.6x | E-18.2% | n/a | ||
| ORGOOrganogenesis Holdings | US$5.98 | -3.1% | -63.6% | US$760.6m | US$14.00 | PS9.1x | E10.1% | n/a | ||
| QPTF.FQuest PharmaTech | US$0.07 | 0% | -30.1% | US$16.0m | n/a | n/a | n/a | n/a |